In addition to its FDA-approved indications, liraglutide is studied for its potential use in other conditions
Bioactivity of growth hormone releasing hormone (1-29) analogues after SC injection in man
[1] These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Some studies suggest that 1 to 3 days of starvation or decreased carbohydrate intake is enough to decrease the need for medication to control type 2 diabetes
Compounded semaglutide and tirzepatide through PlexusDx are formulated by state-licensed pharmacists and typically cost 4050% less than branded alternatives, making them attractive for cost-conscious or uninsured patients
Cagrilintide is long-acting (half-life ~7-8 days)